Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the announcement issued by JD Health International Inc. and disclaim any liability for any loss arising from or in reliance upon its contents.

JD Health International Inc. plans to convene a board meeting on March 5, 2026. The meeting will review and approve the annual results for the year ended December 31, 2025, and consider a final dividend, if any.

Management will host a conference call at 5:00 p.m. (Beijing/Hong Kong Time) on the same day to discuss the financial results. Participants are advised to dial in at least 10 minutes prior to the scheduled start time. The main dial-in numbers include 400 810 8128 (English), 400 810 8228 (Mandarin) for Mainland China, +852 3005 1313 (English), +852 3005 1355 (Mandarin) for Hong Kong, China, +1 6462543594 for the U.S., and +65 68185374 for Singapore. The Mandarin Channel Participant Code is 187150, and the English Channel Participant Code is 611787. Additional global dial-in numbers are available via the provided link in the announcement.

As stated in the announcement, the board of JD Health International Inc. is currently composed of one executive director, one non-executive director, and five independent non-executive directors.